Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs IQIYI Inc - ADR — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43 (market cap $7.04B), while IQIYI Inc - ADR trades at $0.95 (market cap $962.85M). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 7.3× IQIYI Inc - ADR's market cap, and IQIYI Inc - ADR is more actively traded (8,833,890 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and IQIYI Inc - ADR for 55 Days on average.
| IONS | IQ | |
|---|---|---|
Market Cap | $7.04B | $962.85M |
Volume | 2,977,440 | 8,833,890 |
Sector | Health | Media |
52-Week High | $86.50 | $2.35 |
52-Week Low | $42.38 | $0.86 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $6.60B | $2.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IQ trades at $0.9513, down 6.74% over 24 hours amid mixed signals. The stock shows a neutral technical stance with a bullish moving average trend but an overbought RSI. Fundamentally, the company reported a net loss of $206.31 million in 2025 despite beating EPS estimates in recent quarters, with revenue declining to $27.29 billion. Analyst sentiment is split, with 50% recommending buy. Recent news highlights iQIYI's push into AI-driven content, including new titles and revenue-sharing successes.
The outlook is cautious; while AI initiatives offer growth potential, persistent losses and revenue contraction pose risks. Valuation metrics like a high P/E of 144.05 suggest premium pricing relative to earnings, but low P/S and P/B ratios may attract value investors. Key risks include competitive pressures in streaming and reliance on AI content monetization. Investors should weigh innovation bets against financial sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
